Olympia Compounding Pharmacy dba Olympia Pharmacy product recalled over manufacturing violations
- Recall date
- April 4, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Olympia Compounding Pharmacy dba Olympia Pharmacy recalls T-106, Papaverine 30 mg/mL . Phentolamine 1 mg/mL . Alprostadil 25 mcg/mL, Packaged as a) 10 mL Multi-Dose vial, NDC: 7…
- Recall number
- D-0804-2022
- FDA classification
- Class II
- Brand / firm
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Sold / distributed
- Distributed Nationwide in the USA
Why it was recalled
CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
T-106, Papaverine 30 mg/mL . Phentolamine 1 mg/mL . Alprostadil 25 mcg/mL, Packaged as a) 10 mL Multi-Dose vial, NDC: 73198-0013-10; b) 5 mL Multi-Dose vial, NDC 73198-0013-05; Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835.
Get recall alerts
Free email alert whenever Olympia Compounding Pharmacy dba Olympia Pharmacy has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Olympia Compounding Pharmacy dba Olympia Pharmacy